In the Biopharma industry, innovation is usually synonymous with scientific advancement. In this latest episode of ConvergeCast, Jason Hawbecker joins Michael Castleman and Ysette Witteveen to discuss new arenas of innovation focused on "meeting patients where they are—physically or digitally." As Biogen's Senior Vice President and Head of External Growth & Innovation, Hawbecker explains how Biogen is embracing digital technologies, new service models, ai, ai chatbots and diverse partnerships to drive better awareness, access, engagement, onboarding and adherence with patients and caregivers. "We're finally realizing we don't always have to compete. There are opportunities to drive revenue for everyone while improving patient outcomes," he says. Drawing on his experience at CVS Health, Hawbecker highlights how collaboration across the healthcare ecosystem is essential. Whether a partnership with Optum to enhance care for women with postpartum depression or with Delta Airlines to improve travel for wheel-chair bound patients, Hawbecker notes that innovation needs intentionality and rethinking the status quo. "It’s about making life easier for patients," he says. "You can’t measure everything with ROI."

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related